Mechanomind

Mechanomind is a company operating in the New York artificial intelligence scene[1] that applies computer vision and deep learning to cancer diagnostics[2]. The company operates in the biotechnology industry[3]. Mechanomind's dermatology AI tool achieves 99% accuracy across common diagnoses including melanoma, with results validated by an independent laboratory at the University of Chicago Medicine[2]. The tool functions across different scanner types and handles variability in slide quality[2]. The company's diagnostic solution can be deployed locally at laboratory facilities[2]. Mechanomind was founded in 2015[2] and operates with a team of four employees[3].

Something wrong or missing? Send a correction. Fixed within 24 hours.